<VariationArchive RecordType="classified" VariationID="463975" VariationName="NC_000021.9:g.(?_35048836)_(35048905_?)del" VariationType="Deletion" Accession="VCV000463975" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2022-04-25" DateCreated="2017-12-26" MostRecentSubmission="2019-08-18">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="471077" VariationID="463975">
      <GeneList>
        <Gene Symbol="RUNX1" FullName="RUNX family transcription factor 1" GeneID="861" HGNC_ID="HGNC:10471" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>21q22.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="34787801" stop="35049302" display_start="34787801" display_stop="35049302" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="36160097" stop="36421594" display_start="36160097" display_stop="36421594" Strand="-" />
          </Location>
          <OMIM>151385</OMIM>
          <Haploinsufficiency last_evaluated="2012-08-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RUNX1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-08-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RUNX1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000021.9:g.(?_35048836)_(35048905_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>21q22.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" innerStart="35048836" innerStop="35048905" display_start="35048836" display_stop="35048905" variantLength="70" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" innerStart="36421133" innerStop="36421202" display_start="36421133" display_stop="36421202" variantLength="70" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.9" sequenceAccession="NC_000021" sequenceVersion="9" change="g.(?_35048836)_(35048905_?)del" Assembly="GRCh38">
            <Expression>NC_000021.9:g.(?_35048836)_(35048905_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.8" sequenceAccession="NC_000021" sequenceVersion="8" change="g.(?_36421133)_(36421202_?)del" Assembly="GRCh37">
            <Expression>NC_000021.8:g.(?_36421133)_(36421202_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000021.9:g.(?_35048836)_(35048905_?)del AND Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1" Accession="RCV000540519" Version="2">
        <ClassifiedConditionList TraitSetID="3994">
          <ClassifiedCondition DB="MedGen" ID="C1832388">Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2019-08-06" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-08-06" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-12-26" MostRecentSubmission="2019-08-18">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">29666006</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/5d15c32f-47fc-4ba9-8d74-b998374ee11d</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="3994" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3980" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Familial Platelet Disorder with Propensity to Acute Myelogenous Leukemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial platelet disorder with associated myeloid malignancy</ElementValue>
                <XRef ID="Familial+Platelet+Disorder+with+Associated+Myeloid+Malignancy/2765" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial thrombocytopenia with propensity to acute myelogenous leukemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Platelet disorder, Aspirin-like</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1</ElementValue>
                <XRef ID="MONDO:0100083" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FPDMM</ElementValue>
                <XRef Type="MIM" ID="601399" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FPD/AML</ElementValue>
                <XRef Type="MIM" ID="601399" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">RUNX1 familial platelet disorder with associated myeloid malignancies (RUNX1-FPDMM) is characterized by prolonged bleeding and/or easy bruising and an increased risk of developing a hematologic malignancy. RUNX1-FPDMM is characterized by thrombocytopenia with normal platelet size; bleeding is often greater than expected due to qualitative platelet dysfunction. Myeloid malignancies are the most common, including acute myelogenous leukemia (and myelodysplastic syndrome. T- and B-cell acute lymphoblastic leukemias and lymphomas have also been reported, as well as skin manifestations (e.g., eczema, psoriasis).</Attribute>
                <XRef ID="NBK568319" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">33661592</ID>
                <ID Source="BookShelf">NBK568319</ID>
              </Citation>
              <XRef ID="71290" DB="Orphanet" />
              <XRef ID="C1832388" DB="MedGen" />
              <XRef ID="C563324" DB="MeSH" />
              <XRef ID="MONDO:0100083" DB="MONDO" />
              <XRef Type="MIM" ID="601399" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1230621" SubmissionDate="2017-10-05" DateLastUpdated="2017-12-26" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="1348839|MedGen:C1832388" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000638119" DateUpdated="2017-12-26" DateCreated="2017-12-26" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-03-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment Type="public">This variant is a gross deletion of the genomic region encompassing exon 2 of the RUNX1 gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 2 of the RUNX1 gene. This is expected to result in an absent or disrupted protein product. While this particular variant has not been reported in the literature, loss-of-function variants in RUNX1 are known to be pathogenic (PMID: 18723428, 24100448). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RUNX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000021.8:g.(?_36421133)_(36421202_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1832388" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB3109251</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="1893312" SubmissionDate="2019-08-08" DateLastUpdated="2019-08-18" DateCreated="2019-08-18">
        <ClinVarSubmissionID localKey="5d15c32f-47fc-4ba9-8d74-b998374ee11d" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV000965662" DateUpdated="2019-08-18" DateCreated="2019-08-18" Type="SCV" Version="1" SubmitterName="ClinGen Myeloid Malignancy Variant Curation Expert Panel" OrgID="507107" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-08-06">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">29666006</ID>
          </Citation>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/5d15c32f-47fc-4ba9-8d74-b998374ee11d</URL>
          </Citation>
          <Comment>The deletion of exons 1 (non-coding) and 2 or exons 1, 2, and 3, all affecting presumedly exclusively RUNX1 isoform C, are common in FPD/AML patients and currently represent the most common pathogenic CNV in RUNX1. Multiple probands have been reported. These deletions only affect the N-terminal region of isoform C which is not shared by isoforms A and B. Despite the N-terminal region being a functionally unknown part of the protein, isoform C is biologically important und deletions are absent in the population which warrants application of PVS1_Moderate and PM2. Probands and affected family members show the typical FPD/AML phenotype and the deletion segregates with disease in multiple affected family members across multiple families (PP1_Strong). In addition, PS4 can be applied due to 5 probands with FPD/AML were reported from internal laboratories. In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the ClinGen Myeloid Malignancy Variant Curation Expert Panel for RUNX1: PS4, PP1_Strong, PVS1_Moderate, PM2.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen MyeloMalig ACMG Specifications v1</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/wzxvueak/clingen_myelomalig_acmg_specifications_v1.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RUNX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NC_000021.9:g.(?_35048836)_(35048905_?)del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000021.9:g.(?_35048836)_(35048905_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Familial platelet disorder with associated myeloid malignancy</ElementValue>
            </Name>
            <XRef DB="Orphanet" ID="ORPHA71290" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6149563</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1230621" TraitType="Disease" MappingType="XRef" MappingValue="C1832388" MappingRef="MedGen">
        <MedGen CUI="C1832388" Name="Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1893312" TraitType="Disease" MappingType="Name" MappingValue="Familial platelet disorder with associated myeloid malignancy" MappingRef="Preferred">
        <MedGen CUI="C1832388" Name="Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

